SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-21-088553
Filing Date
2021-07-02
Accepted
2021-07-02 07:06:20
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2120989d3_defa14a.htm DEFA14A 18504
2 GRAPHIC tm2120989d3_defa14aimg001.jpg GRAPHIC 316789
3 GRAPHIC tm2120989d3_defa14aimg002.jpg GRAPHIC 112591
  Complete submission text file 0001104659-21-088553.txt   611405
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEFA14A | Act: 34 | File No.: 001-35963 | Film No.: 211067963
SIC: 2834 Pharmaceutical Preparations